Live catalyst feed

Tuesday, October 13, 2026

Every market-moving event Day Trader Sniper classified this session, with HCS category, session chart, and observed market response. Not financial advice.

←→Jump to latest

Regulatory and ClinicalTrial Enrollment CompleteOct 13, 2026 · 8:30am ET

BDRXBiodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals Plc Enrolls 100 Patients in Serenta Phase 3 Trial

The milestone marks significant progress in the trial for FAP treatment.

Regulatory and ClinicalTrial Enrollment CompleteOct 13, 2026 · 8:30am ET

BDRXBiodexa Pharmaceuticals Plc+70.0%

Biodexa Pharmaceuticals Plc Enrolls 100 Patients in Serenta Phase 3 Trial

Be early on the next spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Loading…